Isovanillic Acid Methyl Ester

Isovanillic Acid Methyl Ester

SCHEMBL1560433

COC(=O)c1cc(OCCc2cccc(Cl)c2)c(OC)cc1Cl.COC(=O)c1ccc(OC)c(O)c1

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ LPAR1 Q92633 1/20 0.50
▸ ACHE P22303 1/20 0.45
▸ POLB P06746 1/20 0.43
▸ P4HB P07237 1/20 0.42
▸ HDAC1 Q13547 1/20 0.42
▸ HDAC2 Q92769 1/20 0.42
▸ SCD O00767 1/20 0.41
▸ SIRT2 Q8IXJ6 1/20 0.41
▸ MRGPRX4 Q96LA9 1/20 0.41
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ HSP90AA1 P07900 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Isovanillic Acid Methyl Ester SCHEMBL1560813 0.91 LPAR1 (0.49) LPAR1ACHEPOLBP4HBHDAC1
SCHEMBL1990286 0.90 LPAR1 (0.51) LPAR1ACHEPOLBSIRT2MEN1
Isovanillic Acid Methyl Ester SCHEMBL1561708 0.88 LPAR1 (0.46) LPAR1ACHEPOLBSCDMEN1
SCHEMBL1560333 0.85 LPAR1 (0.64) LPAR1ACHEPOLBHDAC1HDAC2
SCHEMBL1988472 0.80 LPAR1 (0.49) LPAR1ACHEPOLBHDAC1HDAC2
Isovanillic Acid Methyl Ester SCHEMBL1561379 0.78 P4HB (0.47) LPAR1P4HBHDAC1HDAC2SIRT2
SCHEMBL1989114 0.77 LMNA (0.48) LPAR1POLBMEN1KMT2AMAPT
SCHEMBL17844325 0.74 HPGD (0.57) MAPTALDH1A1
SCHEMBL1561673 0.73 LPAR1 (0.56) LPAR1ACHEPOLBHDAC1HDAC2
SCHEMBL17844306 0.72 NPC1 (0.59) HDAC1MEN1KMT2AHSP90AA1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2303270-A1 ACYLAMINO-SUBSTITUTED FUSED CYCLOPENTANECARBOXYLIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS Sanofi-aventis (FR) 2011-04-06 — — EP disclosed
WO-2009135590-A1 ACYLAMINO-SUBSTITUTED FUSED CYCLOPENTANECARBOXYLIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS SANOFI-AVENTIS (FR) 2009-11-12 — — WO disclosed
Send feedback